{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:46:08Z","timestamp":1790736368028,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003056","name":"Ente Cassa di Risparmio di Firenze","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003056","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.bioorg.2020.103896","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T21:03:55Z","timestamp":1588539835000},"page":"103896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["N-aryl-N\u2032-ureido-O-sulfamates as potent and selective inhibitors of hCA VB over hCA VA: Deciphering the binding mode of new potential agents in mitochondrial dysfunctions"],"prefix":"10.1016","volume":"100","author":[{"given":"Giulio","family":"Poli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Bozdag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Berrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziano","family":"Tuccinardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Carta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.103896_b0005","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.cell.2012.02.035","article-title":"Mitochondria: in sickness and in health","volume":"148","author":"Nunnari","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2020.103896_b0010","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2020.103896_b0015","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.redox.2018.03.002","article-title":"Diverse roles of mitochondria in ischemic stroke","volume":"16","author":"Yang","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.bioorg.2020.103896_b0020","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cell.2016.07.002","article-title":"Mitochondria and Cancer","volume":"166","author":"Vyas","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2020.103896_b0025","first-page":"1066","article-title":"Mitochondrial dysfunction and oxidative stress in metabolic disorders - a step towards mitochondria based therapeutic strategies","volume":"2017","author":"Bhatti","year":"1863","journal-title":"Biochim. Biophys. Acta Mol. Basis. Dis."},{"key":"10.1016\/j.bioorg.2020.103896_b0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/CIRCULATIONAHA.111.087213","article-title":"Energy balance and obesity","volume":"126","author":"Hill","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.bioorg.2020.103896_b0035","doi-asserted-by":"crossref","unstructured":"S.D. Pedersen, Metabolic complications of obesity, Best. Pract. Res. Clin. Endocrinol. Metab. 27 (2013) 179\u2013193.","DOI":"10.1016\/j.beem.2013.02.004"},{"key":"10.1016\/j.bioorg.2020.103896_b0040","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.3390\/nu6115153","article-title":"Obesity: pathophysiology and intervention","volume":"6","author":"Zhang","year":"2014","journal-title":"Nutrients"},{"key":"10.1016\/j.bioorg.2020.103896_b0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s13679-018-0300-4","article-title":"Future pharmacotherapy for obesity: new anti-obesity drugs on the horizon","volume":"7","author":"Srivastava","year":"2018","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.bioorg.2020.103896_b0050","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1517\/14728214.13.2.383","article-title":"Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity","volume":"13","author":"Supuran","year":"2008","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.bioorg.2020.103896_b0055","series-title":"Carbonic Anhydrases","first-page":"311","article-title":"Carbonic anhydrase inhibitors for the treatment of epilepsy and obesity","author":"Berrino","year":"2019"},{"key":"10.1016\/j.bioorg.2020.103896_b0060","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/oby.20584","article-title":"Evaluation of phentermine and topiramate versus phentermine\/topiramate extended-release in obese adults","volume":"21","author":"Aronne","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.bioorg.2020.103896_b0065","unstructured":"FDA, New drug application 22580- VI-0521 QNEXA (phentermine\/topiramate). 2012, pp. 1\u2013200."},{"key":"10.1016\/j.bioorg.2020.103896_b0070","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/oby.2000.84","article-title":"Topiramate reduces energy and fat gains in lean (Fa\/?) and obese (fa\/fa) Zucker rats","volume":"8","author":"Picard","year":"2000","journal-title":"Obes. Res."},{"key":"10.1016\/j.bioorg.2020.103896_b0075","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"6","key":"10.1016\/j.bioorg.2020.103896_b0080","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.bmc.2012.06.053","article-title":"Effect of sulfonamides as carbonic anhydrase VA and VB inhibitors on mitochondrial metabolic energy conversion","volume":"21","author":"Arechederra","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103896_b0085","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/febs.14779","article-title":"Carbonic anhydrases are involved in mitochondrial biogenesis and control the production of lactate by human Sertoli cells","volume":"286","author":"Bernardino","year":"2019","journal-title":"FEBS J."},{"key":"10.1016\/j.bioorg.2020.103896_b0090","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1021\/jm050483n","article-title":"Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors","volume":"48","author":"Nishimori","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103896_b0095","doi-asserted-by":"crossref","first-page":"10949","DOI":"10.1073\/pnas.92.24.10949","article-title":"Structure determination of murine mitochondrial carbonic anhydrase V at 2.45-A resolution: implications for catalytic proton transfer and inhibitor design","volume":"92","author":"Boriack-Sjodin","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2020.103896_b0100","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1016\/j.bmcl.2006.05.068","article-title":"N-hydroxyurea\u2013a versatile zinc binding function in the design of metalloenzyme inhibitors","volume":"16","author":"Temperini","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"10","key":"10.1016\/j.bioorg.2020.103896_b0105","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/j.bmcl.2007.03.008","article-title":"Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose\u2013thioureido tails","volume":"17","author":"Winum","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.103896_b0110","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3109\/14756366.2011.606544","article-title":"QSARs on human carbonic anhydrase VA and VB inhibitors of some new not yet synthesized, substituted aromatic\/heterocyclic sulphonamides as anti-obesity agent","volume":"27","author":"Singh","year":"2012","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103896_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103033","article-title":"N-aryl-N'-ureido-O-sulfamates: potent and selective inhibitors of the human carbonic anhydrase VII isoform with neuropathic pain relieving properties","volume":"89","author":"Bozdag","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103896_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2018.02.029","article-title":"Synthesis of N'-phenyl-N-hydroxyureas and investigation of their inhibitory activities on human carbonic anhydrases","volume":"78","author":"Bozdag","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103896_b0125","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2020.103896_b0130","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.bmcl.2012.01.129","article-title":"New chemotypes acting as isozyme-selective Carbonic Anhydrase Inhibitors with low affinity for the offtarget cytosolic isoform II","volume":"22","author":"Carta","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.103896_b0135","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1093\/nar\/gkg563","article-title":"ExPASy: the proteomics server for in-depth protein knowledge and analysis","volume":"31","author":"Gasteiger","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2020.103896_b0140","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","article-title":"Gapped BLAST and PSI-BLAST: a new generation of protein database search programs","volume":"25","author":"Altschul","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2020.103896_b0145","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1093\/nar\/22.22.4673","article-title":"CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice","volume":"22","author":"Thompson","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2020.103896_b0150","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1110\/ps.9.9.1753","article-title":"Modeling of loops in protein structures","volume":"9","author":"Fiser","year":"2000","journal-title":"Protein Sci."},{"key":"10.1016\/j.bioorg.2020.103896_b0155","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2020.103896_b0160","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1021\/ci500209e","article-title":"AutoDock4Zn: an improved autodock force field for small-molecule docking to zinc metalloproteins","volume":"54","author":"Santos-Martins","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2020.103896_b0165","doi-asserted-by":"crossref","unstructured":"M. Krasavin, A. Shetnev, T. Sharonova, S. Baykov, S. Kalinin, A. Nocentini, V. Sharoyko, G. Poli, T. Tuccinardi, S. Presnukhina, T.B. Tennikova, C.T. Supuran, Continued exploration of 1,2,4-oxadiazole periphery for Carbonic Anhydrase-targeting primary arene sulfonamides: discovery of subnanomolar inhibitors of membrane-bound HCA IX isoform that selectively kill cancer cells in hypoxic environment, Eur. J. Med. Chem. 164 (2019) 92\u2013105. [28] Bononi G et al., Eur J Med Chem. 2018;157:817-836.","DOI":"10.1016\/j.ejmech.2018.12.049"},{"key":"10.1016\/j.bioorg.2020.103896_b0170","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1021\/acs.jnatprod.6b00627","article-title":"Drug affinity responsive target stability (DARTS) identifies laurifolioside as a new clathrin heavy chain modulator","volume":"79","author":"Dal Piaz","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2020.103896_b0175","unstructured":"D.A. Case, J.T. Berryman, R.M. Betz, D.S. Cerutti, Darden, R.E. Duke, T.J. Giese, H. Gohlke, A.W. Goetz, N. Homeyer, S. Izadi, P. Janowski, J. Kaus, A. Kovalenko, T.S. Lee, S. LeGrand, P. Li, T. Luchko, R. Luo, B. Madej, K.M. Merz, G. Monard, P. Needham, H. Nguyen, H.T. Nguyen, I. Omelyan, A. Onufriev, D.R. Roe, A. Roitberg, R. Salomon-Ferrer, C.L. Simmerling, W. Smith, J. Swails, R.C. Walker, J. Wang, R.M. Wolf, X. Wu, D.M. York, P.A. Kollman, AMBER, Version 16, University of California, San Francisco, CA, 2016."},{"key":"10.1016\/j.bioorg.2020.103896_b0180","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ejmech.2018.06.033","article-title":"Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents","volume":"155","author":"Chiarelli","year":"2018","journal-title":"Eur. J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820307082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820307082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:03:04Z","timestamp":1758614584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206820307082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":36,"alternative-id":["S0045206820307082"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103896","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-aryl-N\u2032-ureido-O-sulfamates as potent and selective inhibitors of hCA VB over hCA VA: Deciphering the binding mode of new potential agents in mitochondrial dysfunctions","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103896","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103896"}}